Skip to main content
. 2013 Sep 10;347:f5264. doi: 10.1136/bmj.f5264

Table 2.

 Multilevel analyses for differences between control group (CG) and intervention group (IG) for primary outcome measures at 6, 12, and 24 months’ follow-up (n=310)

Outcome 6 months’ follow-up 12 months’ follow-up 24 months’ follow-up
Mean (SD) Mean difference* (95% CI); P value Mean (SD) Mean difference* (95% CI); P value Mean (SD) Mean difference* (95% CI); P value
CG IG CG IG CG IG
GARS 30.16 (10.07) 32.83 (10.98) 0.41 (−0.80 to 1.62); 0.51 30.81 (10.29) 33.08 (11.34) 0.47 (−0.81 to 1.76); 0.47 31.50 (10.92) 34.39 (11.58) 1.18 (−0.35 to 2.71); 0.35
GARS ADL 16.17 (5.13) 17.54 (5.82) 0.25 (−0.44 to 0.94); 0.48 16.30 (5.31) 17.81 (5.90) 0.59 (−0.14 to 1.33);0.11 16.73 (5.73) 18.31 (5.82) 0.77 (−0.05 to 1.59); 0.07
GARS IADL 14.00 (5.51) 15.29 (5.92) 0.17 (−0.63 to 0.97); 0.67 14.51 (5.69) 15.28 (6.03) −0.12 (−0.93 to 0.68); 0.76 14.77 (5.86) 16.08 (6.35) 0.40 (−0.54 to 1.34); 0.41

GARS=Groningen Activity Restriction Scale (range total scale 18-78; higher scores indicate more disability); GARS ADL=Groningen Activity Restriction Scale—activities of daily living (ADL) subscale (range total scale 11-44; higher scores indicate more disability); GARS IADL=Groningen Activity Restriction Scale—instrumental ADL subscale (range total scale 7-28; higher scores indicate more disability).

*Adjusted for age, sex, education, and significant differences at baseline (frailty and disability).